World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23063
World Ranking
18019
National Ranking
8984

Overview

Thomas C. Hamilton is affiliated with Fox Chase Cancer Center in the United States. The center is known for its work in cancer research and treatment, though specific details about Hamilton's research focus within this environment are not available.

There are no available records of recent papers, book publications, or detailed main fields and subfields of study linked to Hamilton. Similarly, information on frequent co-authors and publication venues has not been provided.

Without explicit data on research topics, publications, or awards, it is not possible to detail specific areas of scientific contribution or recognition. The absence of such information limits the scope to confirm the scientist's specialization or thematic interests in academic research.

Hamilton is actively working and is not deceased.

Best Publications

  • High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

    Andrew K. Godwin;Alton Meister;Peter J. O'Dwyer;Chin Shiou Huang

  • AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

    Jin Quan Cheng;Andrew K. Godwin;Alfonso Bellacosa;Takahiro Taguchi

  • Platinum resistance: the role of DNA repair pathways.

    Lainie P. Martin;Thomas C. Hamilton;Russell J. Schilder

  • Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors

    Thomas C. Hamilton;Robert C. Young;Wilma M. McKoy;Karen R. Grotzinger

  • Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

    Thomas C. Hamilton;Margaret A. Winker;Karen G. Louie;Gerald Batist

  • Characterization of a cis-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues

    Brent C. Behrens;Brent C. Behrens;Thomas C. Hamilton;Hidetaka Masuda;Karen R. Grotzinger

  • Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

    Robert F. Ozols;Robert E. Cunnion;Raymond W. Klecker;Thomas C. Hamilton

  • Reversal of adriamycin resistance by verapamil in human ovarian cancer

    Alfred M. Rogan;Thomas C. Hamilton;Robert C. Young;Raymond W. Klecker

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Radiation Survival Parameters of Antineoplastic Drug-sensitive and -resistant Human Ovarian Cancer Cell Lines and Their Modification by Buthionine Sulfoximine

    Karen G. Louie;Brent C. Behrens;Timothy J. Kinsella;Thomas C. Hamilton

  • Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

    Muthu Selvakumaran;Debra A Pisarcik;Rudi Bao;Anthony T Yeung

  • Focus on epithelial ovarian cancer.

    Robert F. Ozols;Michael A. Bookman;Denise C. Connolly;Mary B. Daly

  • Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer

    Denise C. Connolly;Rudi Bao;Alexander Yu Nikitin;Kasie C. Stephens

  • Increased DNA Repair as a Mechanism of Acquired Resistance to cis-Diamminedichloroplatinum(II) in Human Ovarian Cancer Cell Lines

    Hidetaka Masuda;Robert F. Ozols;Gi-Ming Lai;Antonio Fojo

  • Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic Oophorectomies

    H Salazar;A K Godwin;M B Daly;P B Laub

  • Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

    Katherine V Ferry;Thomas C Hamilton;Steven W Johnson

  • Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

    J A Green;D T Vistica;R C Young;T C Hamilton

  • The biology of ovarian cancer

    N. Auersperg;M. I. Edelson;S. C. Mok;S. W. Johnson

  • Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.

    Robert F. Ozols;Karen G. Louie;Jacqueline Plowman;Brent C. Behrens

  • Evidence for Altered Regulation of γ-Glutamylcysteine Synthetase Gene Expression among Cisplatin-sensitive and Cisplatin-resistant Human Ovarian Cancer Cell Lines

    Kang-Shen Yao;Andrew K. Godwin;Steven W. Johnson;Robert F. Ozols

Frequent Co-Authors

Robert F. Ozols
Robert F. Ozols Fox Chase Cancer Center
Peter J. O'Dwyer
Peter J. O'Dwyer University of Pennsylvania
Robert C. Young
Robert C. Young Cornell University
Joseph R. Testa
Joseph R. Testa Fox Chase Cancer Center
Andres J. P. Klein-Szanto
Andres J. P. Klein-Szanto Fox Chase Cancer Center
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Henry T. Lynch
Henry T. Lynch Creighton University
Martin Gore
Martin Gore Royal Marsden NHS Foundation Trust
Ira Pastan
Ira Pastan Center for Cancer Research
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens up a variety of online degree options and alternative entry routes. Many students now seek direct entry MSN programs for non-nurses online to transition into advanced nursing roles, even if their undergraduate degree isn’t related to healthcare. These programs are ideal for those looking for a quick, flexible pathway to a master’s in nursing.

If you want to start your nursing education sooner, consider direct admit nursing programs. These options often have less stringent prerequisites and let you begin clinical training earlier. Plus, some top schools now offer admissions without requiring standardized entrance tests such as the TEAS or HESI. Learn more about the requirements at do you have to take the teas test to get into nursing school.

Prefer a non-clinical healthcare career? Accredited medical billing and coding schools that accept fafsa provide solid options, offering essential skills for administrative roles and making education more affordable with financial aid.

Best Scientists Citing Thomas C. Hamilton

Recently Published Articles